We would like to thank everyone who entered our 2019 Abstract Competition. This event is an excellent opportunity for our team to hear the unique ways Golden Helix software is being applied around the world. We had a number of remarkable entries this year which made our selection process a daunting one, indeed. It is my pleasure to announce this… Read more »
I am excited to announce the release of my new eBook “Clinical Variant Analysis – Applying ACMG Guidelines to Analyze Germline Diseases“! You can download your complimentary by clicking on the button below. The clinical interpretation of variants in Next-Gen Sequencing is a quickly evolving field. While the body of knowledge is growing exponentially, experts have to derive sound, clinical decisions leveraging an… Read more »
Our team is more than ready to escape the cold at Golden Helix HQ for an eventful week at PAG XXVII in San Diego, CA! If you are attending the conference, we hope you will stop by our booth and say hello to the team: Dr. Andreas Scherer, Darby Kammeraad, and myself. We would love the opportunity to connect with… Read more »
We are honored to announce that we have been named one of the Top 10 Biotechnology Solution Providers for the second year in a row by CIO Applications. We are at a point where precision medicine is taking off.The Centers for Medicare & Medicaid Services (CMS) has started to reimburse testing labs for NGS-based tests. This is a game changer… Read more »
We just got back from three busy days at the Molecular Pathology (AMP) conference in friendly San Antonio, Texas. Keeping up the Golden Helix conference momentum for the year, we had 3-4 in-booth demonstrations a day covering our CNV calling, variant interpretation, and data warehousing products for NGS-based genetic tests. And in short, NGS based tests for cancer and germline… Read more »
We’ve packed our bags and we’re off to The Lone Star State to take part in the Association for Molecular Pathology Annual Meeting and Expo (AMP 2018)! As first-time attendees, we’re looking forward to integrating ourselves in the AMP community and showcasing our clinical stack, including VSClinical released earlier this year. Come on over and introduce yourself, you’ll find us… Read more »
Following a wonderful September with our 20th Anniversary and being awarded an NIH-SBIR Phase 2 Grant, October has been nothing short of exciting for us here at Golden Helix. We know that none of our success could happen without the continuous support all of you show us – so thank you to everyone who is a part of this awesome… Read more »
As we are beginning to welcome the crisp fall weather here in Montana, we cannot wait to make an escape to the warm, sunny weather of San Diego, CA for the American Society of Human Genetics Annual Meeting (ASHG 2018). We are looking forward to spending the week discussing with new and familiar faces within the genetics industry. If you… Read more »
It is our distinct pleasure to inform the GHI community that we have been awarded a Phase II SBIR Grant from the National Institutes of Health. As we are also preparing to celebrate our 20th Anniversary, these two events invoke a lot of excitement within our company and what lies ahead, for not GHI only, but the genetics field entirely…. Read more »
Celebrating our 20th Anniversary on September 15th, we took some time to reflect on the last two decades in this industry. Two decades of learning, adaption, and growth on the business side as well as the personal side. Employees began their careers with us, made new friends and started their own families. These past 20 years are full of stories… Read more »
Check out some information on the upcoming release of new genome maps and annotation tracks for a few animal species.
We’re looking forward to seeing everyone at ESHG 2018 in Milano, Italy. Both Gabe Rudy and I will be representing the Golden Helix Team and hope that you will stop by to say hello! We will be in booth #312 which I’ve highlighted in the photo below: As always, we have put together a series of quick, in-booth demos that… Read more »
We are incredibly honored to be recognized as one of the Top 10 Analytics Solution Providers of 2018 by Pharma Tech Outlook. “Through innovative products, Golden Helix has been simplifying the clinical workflows and genomic testing for numerous labs. For instance, Prevention Genetics, a clinical testing laboratory offering genetic and DNA banking services with the largest menu of gene sequencing… Read more »
Ready to take your analysis to the next level? Our Small-Lab VarSeq PowerPack enables users to move their analysis from FASTQ to clinical reporting through one streamlined pipeline. Here’s what’s included: VarSeq VarSeq is an intuitive, integrated software solution for tertiary analysis. With VarSeq you can automate your workflows and analyze variants for gene panels, exomes, and whole genomes. VS-CNV… Read more »
Our abstract competition is one of my favorite events because of the learning opportunity it provides our team. Each applicant’s submission tells us a unique story about how our software is helping users conduct their research. This year’s competition didn’t disappoint bringing a new round of fascinating studies to our attention. However, with all these great abstracts came the difficult… Read more »
Awarded one of the top biotech companies Insight Success recently published its annual Pharma and Life Special Edition announcing the 10 most innovative solution providers of 2018. We are incredibly honored to have received this award and being recognized amongst the top biotech companies! You can access the publication featuring my interview with the editor here: http://www.insightssuccess.com/golden-helix-helping-researchers-clinicians-understand-role-cnvs-human-health-disease/. I have outlined some… Read more »
2017 was an incredibly prosperous year for Golden Helix; we released a handful of new features, announced new partnerships and completed our end-to-end architecture for clinical testing labs. Our webcast series has become a very popular way for our community to stay up-to-date with our new capabilities and best practices in genetic analysis using our software. We had three webcast… Read more »
One of our main focuses in 2017 was VS-CNV which allows clinicians to directly call CNVs in target regions quicker, easier and more affordably than CMA or MLPA testing. Our clients at Robarts Research Institute shared their recent publication with me which confirms that our time and dedication to our CNV capabilities was well worth it. I am delighted to… Read more »
The Golden Helix SNP & Variation Suite (SVS) platform is a powerful and versatile set of tools and algorithms for performing genomic research. That research spans from data originating on genotype micro-arrays to next-generation sequencing. While the majority of SVS users start with genotype data on their samples, any genomic information across a cohort can be used in our various… Read more »
It is a great honor for us to be recognized as one of the “Top 25 Biotechnology Solution Providers of 2017” by CIO Applications. You can find my interview with the editor here. We are incredibly thankful for the hundreds of organizations and thousands of users globally trusting our brand! Thank you for your support.